Hopfield Neural Network for the segmentation of Near Infrared Fluorescent images for diagnosing prostate cancer

Although prostate cancer can be a slow-growing cancer, thousands of men die of the disease each year. Over the last decade, the nature of diagnostic healthcare has changed rapidly owing to an explosion in the availability of patient data, which are used as input data to Computed-Aided Diagnosis systems. The aim of this research is to develop a prototype system for the detection and classification of prostate tumors using Near-infrared and Mid-infrared spectrums of prostate pathological images. This optical imaging technique is a potent tool in cancer investigation that relies on stimulating endogenous chromophores or applying contrast agents able to target cancer cells. Here, we present a segmentation method of images obtained using Prostate Specific Membrane Antigen (PSMA) targeted Near Infrared Fluorescence (NIRF) optical imaging probes for intraoperative visualization of prostate cancer. An Artificial Neural Network classifies the pixels into distinguished clusters. Preliminary results demonstrate that the proposed segmentation method can enhance the existing clinical practice in identifying prostate area in the NIRF image, shape and volume analysis could be conducted using the segmentation result for further investigations.

[1]  Georges von Degenfeld,et al.  Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.

[2]  Miriam Scadeng,et al.  Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.

[3]  James P Basilion,et al.  Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer , 2014, Molecular Cancer Therapeutics.

[4]  Jianlin Yuan,et al.  Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field , 2014, International journal of nanomedicine.

[5]  George L. Wright,et al.  Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids , 1995, International journal of cancer.

[6]  Martin G Pomper,et al.  68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. , 2010, Journal of medicinal chemistry.

[7]  Zhenghong Lee,et al.  Targeted treatment of prostate cancer , 2007, Journal of cellular biochemistry.

[8]  Alexander L. Vahrmeijer,et al.  Optical Image-guided Surgery—Where Do We Stand? , 2010, Molecular Imaging and Biology.

[9]  Dongfeng Pan,et al.  Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer , 2013, Translational andrology and urology.

[10]  M. Sadelain,et al.  A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy? , 2001, Critical reviews in immunology.

[11]  P. Low,et al.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results , 2011, Nature Medicine.

[12]  Peter L. Choyke,et al.  Rapid Cancer Detection by Topically Spraying a γ-Glutamyltranspeptidase–Activated Fluorescent Probe , 2011, Science Translational Medicine.

[13]  G. Prendergast Molecular cancer therapeutics : strategies for drug discovery and development , 2005 .

[14]  Andrew E. Sloan,et al.  Topical Application of Activity-based Probes for Visualization of Brain Tumor Tissue , 2012, PloS one.

[15]  Yue Wang,et al.  A Modified Deterministic Annealing Algorithm for Robust Image Segmentation , 2008, Journal of Mathematical Imaging and Vision.

[16]  Rachid Sammouda,et al.  Agriculture satellite image segmentation using a modified artificial Hopfield neural network , 2014, Comput. Hum. Behav..

[17]  Ralph Weissleder,et al.  Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.

[18]  Kinneret Keren,et al.  Dynamic imaging of protease activity with fluorescently quenched activity-based probes , 2005, Nature chemical biology.

[19]  A. Deblasio,et al.  Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. , 1994, Cancer research.

[20]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[21]  Slave Trajanoski,et al.  Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis , 2009, Pathology & Oncology Research.

[22]  Prabhjot Kaur,et al.  Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  Martin G Pomper,et al.  A low molecular weight PSMA-based fluorescent imaging agent for cancer. , 2009, Biochemical and biophysical research communications.

[24]  Nina M. Muñoz,et al.  Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.

[25]  Sabrina S Wilson Radiology , 1938, Glasgow Medical Journal.

[26]  Xavier Llorà,et al.  Towards better than human capability in diagnosing prostate cancer using infrared spectroscopic imaging , 2007, GECCO '07.

[27]  Michael E. Phelps,et al.  Molecular Imaging and Biology , 2003 .